Tumor-induced B cell changes reveal potential biomarker for treatment response in triple negative breast cancer

Researchers have discovered new insights into tumor-induced B cell changes in blood and bone marrow of triple negative breast cancer patients. The findings show two distinct patterns of B cell abnormalities that could serve as blood biomarkers for determining likelihood of response to standard-of-care chemotherapy and immunotherapy.

from Breast Cancer News -- ScienceDaily https://ift.tt/PE08aXh